Oporto, Zeironn M.

HRN: 26-27-91  Sex: Male

Patient Encounter


Audit Details

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/26/2024
ERYTHROMYCIN 0.5%, 3.5G EYE OINTMENT (TUBE)
11/26/2024
11/26/2024
OU
0.5mg
Once
NB Care
Waiting Final Action 

Indication:  Empiric    Type of Infection:  Skin & Soft Tissue    Compliance to guidelines: Compliant To Guidelines

Initial appropriateness: Yes   

Final appropriateness: Yes   

Overall appropriateness: Yes 

Intervention



Type of Intervention done:

                    

           


Acceptance: